Prokineticin 1 and leukemia inhibitory factor mRNA expression in the endometrium of women with idiopathic recurrent pregnancy loss

Basit Öğe Kaydı
dc.authoridCelik, ebru/0000-0002-0774-4294
dc.authoridCigremis, Yilmaz/0000-0002-8600-0946
dc.authoridKaraer, Abdullah/0000-0002-2010-6211
dc.authorwosidCigremis, Yilmaz/JAC-8451-2023
dc.authorwosidCelik, ebru/X-4343-2019
dc.authorwosidCigremis, Yilmaz/O-6019-2015
dc.authorwosidKaraer, Abdullah/ABI-4667-2020
dc.contributor.authorKaraer, Abdullah
dc.contributor.authorCigremis, Yilmaz
dc.contributor.authorCelik, Ebru
dc.contributor.authorGonullu, Rukiye Urhan
dc.date.accessioned2024-08-04T20:39:53Z
dc.date.available2024-08-04T20:39:53Z
dc.date.issued2014
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: To determine the expression patterns of prokineticin 1 (PROK1) and leukemia inhibitory factor (LIF) mRNA differ in peri-implantation endometrial tissue of women with idiopathic recurrent pregnancy loss (RPL) from normal fertile women. Design: A case-control study. Setting: University-based tertiary care center. Patient(s): 30 women with idiopathic RPL and 30 fertile controls. Intervention(s): Endometrial biopsies. Main Outcome Measure(s): Real-time polymerase chain reaction analysis for expression of PROK1 and LIF mRNA. Result(s): The expression of PROK1 and LIF was statistically significantly increased in the endometrium of the women with idiopathic RPL compared with the controls. Furthermore, increased LIF expression was observed in the endometrium of women with idiopathic RPL compared with controls. Conclusion(s): An increased mRNA expression of PROK1 and LIF could be one of the several abnormalities characterizing the endometrium in women with RPL. (C) 2014 by American Society for Reproductive Medicine.en_US
dc.identifier.doi10.1016/j.fertnstert.2014.07.010
dc.identifier.endpageU577en_US
dc.identifier.issn0015-0282
dc.identifier.issn1556-5653
dc.identifier.issue4en_US
dc.identifier.pmid25128195en_US
dc.identifier.scopus2-s2.0-84908227043en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1091en_US
dc.identifier.urihttps://doi.org/10.1016/j.fertnstert.2014.07.010
dc.identifier.urihttps://hdl.handle.net/11616/96576
dc.identifier.volume102en_US
dc.identifier.wosWOS:000343108200031en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofFertility and Sterilityen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLeukemia inhibitory factor (LIF)en_US
dc.subjectprokineticin 1 (PROK1)en_US
dc.subjectrecurrent pregnancy lossen_US
dc.titleProkineticin 1 and leukemia inhibitory factor mRNA expression in the endometrium of women with idiopathic recurrent pregnancy lossen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu